Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
CareTrust REIT ( (CTRE) ) just unveiled an announcement.
On October 21, 2025, CareTrust REIT‘s Board of Directors expanded from five to six members, appointing Gregory K. Stapley as a director effective January 1, 2026. Stapley, a former President and CEO of CareTrust, brings extensive leadership and expertise in the healthcare real estate sector, which is expected to benefit the company’s growth strategy. Additionally, the Board approved amendments to the company’s bylaws to align with SEC universal proxy rules and update nomination procedures, enhancing governance and operational efficiency.
The most recent analyst rating on (CTRE) stock is a Hold with a $37.00 price target. To see the full list of analyst forecasts on CareTrust REIT stock, see the CTRE Stock Forecast page.
Spark’s Take on CTRE Stock
According to Spark, TipRanks’ AI Analyst, CTRE is a Outperform.
CareTrust REIT’s strong financial performance and positive earnings call are the most significant factors driving the overall score. The company’s robust profitability, revenue growth, and strategic investments support a positive outlook. While the technical analysis and valuation indicate some caution, the overall financial health and growth prospects make it a compelling investment opportunity.
To see Spark’s full report on CTRE stock, click here.
More about CareTrust REIT
CareTrust REIT, Inc. is a self-administered, publicly-traded real estate investment trust focused on the ownership, acquisition, development, and leasing of skilled nursing, senior housing, and other healthcare-related properties. The company operates a portfolio of long-term net-leased properties across the United States and United Kingdom, pursuing growth opportunities both domestically and internationally.
Average Trading Volume: 2,415,982
Technical Sentiment Signal: Buy
Current Market Cap: $7.85B
Learn more about CTRE stock on TipRanks’ Stock Analysis page.